摘要
背景:阿尔茨海默病(AD)是世界各国公共卫生的优先事项。与这种疾病作斗争的困难主要在于症状和原因的复杂性,对其机制的了解仍然不足,以及存在潜在的、无症状的、临床前阶段。尽管在治疗阿尔茨海默病的临床研究中不断筛选出许多药物,但由于患者反应的意外缺乏,有时还有一些重要的副作用,使其成为个性化医学的潜在应用领域。目的:提出纳米技术作为个性化药物在AD中应用的一种有价值的工具。方法:个体化医学的目的主要是基于对个体遗传学和疾病进展的了解,以及药物动力学和对现有药物的代谢反应,开发出更多的病人精确的治疗方法。优化新的、更灵敏的检测技术是获取预测和理解病人反应所需的数据池的重要工具。结果:生物传感器的研究已经为AD的核心和新的生物标志物提供了高灵敏度的例子。在治疗中,纳米粒子表面的功能化可以为生物识别或提高生物利用度增加特异性。这将允许使用较低剂量的药物,但由于当地的靶向作用,副作用较小。结论:考虑到纳米粒子作为精细药物开发的优良候选工具的优良特性,建立更好的安全评价和生产规模的标准方法将有利于纳米材料的有成效的应用。
关键词: 纳米粒子,阿尔茨海默病,精密医学,纳米技术,靶向医学,生物传感器,神经变性。
Current Medicinal Chemistry
Title:Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer’s Disease Treatment
Volume: 25 Issue: 35
关键词: 纳米粒子,阿尔茨海默病,精密医学,纳米技术,靶向医学,生物传感器,神经变性。
摘要: Background: Alzheimer’s disease (AD) is a public health priority all over the world. The difficulty of fighting the disease consists mostly in the complexity of symptoms and causes, in the still poor knowledge of its mechanisms and in the existence of a latent, asymptomatic, preclinical stage. Although many drugs are continuously screened in clinical studies for the treatment of Alzheimer’s disease, the unexpected lack of patient response and sometimes the important adverse effects make it a potential field of application for personalized medicine.
Objective: This perspective review proposes nanotechnology as a valuable tool for the application of personalized medicine to AD.
Methods: The aim of personalized medicine is the development of more patient-precise treatments based mostly on the knowledge of individual genetics as well as of disease progress, and of pharmacokinetics and metabolic response to available drugs. The optimization of new and more sensitive detection techniques is an important tool for obtaining the pool of data needed for prediction and understanding of patient response.
Results: Research in bionanosensors is already providing examples with high sensitivity for core and new biomarkers for AD. In therapy the functionalization of nanoparticle surface can add specificity for biological recognition or for improving the bioavailability. This would allow the administration of lower doses with less adverse effects due to the local targeting.
Conclusion: Taking into account the promising characteristics of nanoparticles as excellent candidate tools for precision medicine development, the establishment of better standard methods for safety assessment and production scale up would be desirable for the nanomaterial fruitful employment.
Export Options
About this article
Cite this article as:
Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer’s Disease Treatment, Current Medicinal Chemistry 2018; 25 (35) . https://dx.doi.org/10.2174/0929867324666171012112026
DOI https://dx.doi.org/10.2174/0929867324666171012112026 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises
CNS & Neurological Disorders - Drug Targets The Interactions Between Alzheimer’s Disease and Major Depression: Role of Ca<sup>2+</sup> Channel Blockers and Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Potential Application of Biliverdin Reductase and its Fragments to Modulate insulin/IGF-1/MAPK/PI3-K Signaling Pathways in Therapeutic Settings
Current Drug Targets Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
Current Neuropharmacology Quality of Education and Memory Test Performance in Older Men: The New York University Paragraph Recall Test Normative Data
Current Alzheimer Research Management of Vasculopathy in Connective Tissue Disease
Current Rheumatology Reviews Dual Cross-Talk between Nitric Oxide and D-Serine in Astrocytes and Neurons in the Brain
Central Nervous System Agents in Medicinal Chemistry The Impact of Depressive Symptoms on the Quality of Life of Patients with Type 2 Diabetes in Jazan Region, KSA
Current Diabetes Reviews A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets Restoration of the Immune Balance by Autologous Bone Marrow Transplantation in Juvenile Idiopathic Arthritis
Current Stem Cell Research & Therapy Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Anti-Inflammatory Effects of C-Peptide Prevent Endothelial Dysfunction in Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Changes in Cognition, Depression and Quality of Life after Carotid Stenosis Treatment
Current Neurovascular Research Paroxetine Hydrochloride Push-pull Osmotic Pump Tablets: Designing an Innovative, Scalable Push-pull Osmotic Drug Delivery System Using QbD Approach
Drug Delivery Letters In vivo Proton Magnetic Resonance Spectroscopy and its Applications in Autistic Disorder
Current Molecular Imaging (Discontinued) Beyond Rodent Models of Pain: Non-Human Primate Models for Evaluating Novel Analgesic Therapeutics and Elaborating Pain Mechanisms
CNS & Neurological Disorders - Drug Targets Synaptic Plasticity, Metaplasticity and Depression
Current Neuropharmacology Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises
Current Neuropharmacology Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Enhancement of Hippocampal Plasticity by Physical Exercise as a Polypill for Stress and Depression: A Review
CNS & Neurological Disorders - Drug Targets